FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ricard Cervera

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Thrombosis

Physiology

Pregnancy

Concepts & Ideas

Procedures

Enzyme-Linked Immunosorbent Assay

Co-author Network

Publications

TOP 3
Ricard Cervera; A Gil-Aguado; L J Hernández-Pastor; Lucio Pallarés; I Rúa-Figueroa; J M Sabio; M Iglesias
Direct cost of management and treatment of active systemic lupus erythematosus and its flares in Spain: the LUCIE Study.
Antonio-Javier Chamorro; Antonia Calvo; Ricard Cervera; Ignacio Hernández-García; Miguel Marcos; Juan-Carlos Mejia; Gerard Espinosa
Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Behçet's disease: a systematic review and meta-analysis.
Gerard Espinosa; José A Gomez-Puerta; Guillermo Pons-Estel; Ignasi Rodríguez-Pintó; Ricard Cervera
Relapsing catastrophic antiphospholipid syndrome potential role of microangiopathic hemolytic anemia in disease relapses.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ricard Cervera (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ricard Cervera; A Gil-Aguado; L J Hernández-Pastor; Lucio Pallarés; I Rúa-Figueroa; J M Sabio; M Iglesias
Direct cost of management and treatment of active systemic lupus erythematosus and its flares in Spain: the LUCIE Study.
Revista clínica española 2013;213(3):127-37.
2013: Antonio-Javier Chamorro; Antonia Calvo; Ricard Cervera; Ignacio Hernández-García; Miguel Marcos; Juan-Carlos Mejia; Gerard Espinosa
Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Behçet's disease: a systematic review and meta-analysis.
Autoimmunity reviews 2013;12(5):607-16.
2013: Gerard Espinosa; José A Gomez-Puerta; Guillermo Pons-Estel; Ignasi Rodríguez-Pintó; Ricard Cervera
Relapsing catastrophic antiphospholipid syndrome potential role of microangiopathic hemolytic anemia in disease relapses.
Seminars in arthritis and rheumatism 2013;42(4):417-23.
2012: M Ángeles Martínez-Zamora; Ricard Cervera; Juan Balasch
Recurrent miscarriage, antiphospholipid antibodies and the risk of thromboembolic disease.
Clinical reviews in allergy & immunology 2012;43(3):265-74.
2012: Ricardo Silvariño; Álvaro Danza; Adriana Bérez; Gerard Espinosa; Enrique Méndez; Valentina Mérola; Ricard Cervera
Venous thromboembolic disease in systemic autoimmune diseases: an association to keep in mind.
Autoimmunity reviews 2012;12(2):289-94.
2012: C Catoggio; Ricard Cervera; A Alvarez-Uría; P L Fernandez; Gerard Espinosa
Catastrophic antiphospholipid syndrome triggered by fulminant disseminated herpes simplex infection in a patient with systemic lupus erythematosus.
Lupus 2012;21(12):1359-61.
2012: Daniela Perra; Raquel Ríos-Fernández; Marina Mesquida; Norberto Ortego; Alfredo Adán; Marco A Alba; José Luis Callejas; Ricard Cervera; Gerard Espinosa
Adalimumab for the treatment of Behçet's disease: experience in 19 patients.
Rheumatology (Oxford, England) 2012;51(10):1825-31.
2012: Ricard Cervera
8th International Congress on Autoimmunity: new perspectives for refractory catastrophic antiphospholipid syndrome.
Expert review of clinical immunology 2012;8(7):617-9.
2012: Ricard Cervera; Gerard Espinosa
Connective tissue diseases: classification criteria for SLE: the latest-but not least-attempt.
Nature reviews. Rheumatology 2012;8(9):506-7.
2012: Antonio-Javier Chamorro; Miguel Marcos; JA Mirón Canelo; Ricard Cervera; Gerard Espinosa
Val247Leu β2-glycoprotein-I allelic variant is associated with antiphospholipid syndrome: systematic review and meta-analysis.
Autoimmunity reviews 2012;11(10):705-12.
2012: Ricard Cervera
CAPS Registry.
Lupus 2012;21(7):755-7.
2012: Ricard Cervera
European Forum On Antiphospholipid Antibodies: brief history report and governance document.
Lupus 2012;21(7):699-703.
2012: Ricard Cervera; Gerard Espinosa
Update on the catastrophic antiphospholipid syndrome and the "CAPS Registry".
Seminars in thrombosis and hemostasis 2012;38(4):333-8.
2012: Ricard Cervera; Fabrizio Conti; Andrea Doria; Luca Iaccarino; Guido Valesini
Does seronegative antiphospholipid syndrome really exist?
Autoimmunity reviews 2012;11(8):581-4.
2012: Alfonso Zamora-Ustaran; Ricardo O Escarcega-Alarcón; Enrique Faugier; Mario Garcia-Carrasco; Aurelio Lopez-Colombo; Samara Mendieta-Zeron; Claudia Mendoza-Pinto; Alvaro Montiel-Jarquin; Margarita Muñoz-Guarneros; Ricard Cervera
Antiphospholipid syndrome in Mexican children.
The Israel Medical Association journal : IMAJ 2012;14(5):286-9.
2012: J M Antón; P Castro; Ricard Cervera; Gerard Espinosa; M Gandía; M Marcos; R Merchán; J M Nicolás
Mortality and long term survival prognostic factors of patients with systemic autoimmune diseases admitted to an intensive care unit: a retrospective study.
Clinical and experimental rheumatology 2012;30(3):338-44.
2012: Maria S Stoenoiu; Maria Tektonidou; Carlos Vasconcelos; Selda Aydin; Ricard Cervera; Jean-Pierre Cosyns; David D'Cruz; Michel Delahousse; Geneviève Depresseux; Christoph Fiehn; Inge-Magrethe Gilboe; Loïc Guillevin; Frédéric A Houssiau; Michel Jadoul; Alexandre Karras; Véronique le Guern; Peter Petera; Thomas Quémeneur; Isabelle Ravelingien; Philippe Remy
Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27(5):1924-30.
2012: Maria Angeles Martinez-Zamora; Sara Peralta; Joan Carles Reverter; Dolors Tassies; Francisco Carmona; Ricard Cervera; Montserrat Creus; Gerard Espinosa; Juan Balasch
Risk of thromboembolic events after recurrent spontaneous abortion in antiphospholipid syndrome: a case-control study.
Annals of the rheumatic diseases 2012;71(1):61-6.
2011: Guillermo J Pons-Estel; Gabriel E Salerni; Rosa M Serrano; José A Gomez-Puerta; Miguel Lozano; Miguel A Plasin; Edelweiss Aldasoro; Ricard Cervera; Joan Cid; Gerard Espinosa
Therapeutic plasma exchange for the management of refractory systemic autoimmune diseases: report of 31 cases and review of the literature.
Autoimmunity reviews 2011;10(11):679-84.
2011: M Marcos; J Mensa; A Soriano; J A Martínez; M Almela; Ricard Cervera; C Fernández; F Marco; Gerard Espinosa
Epidemiology and clinical outcomes of bloodstream infections among lupus patients.
Lupus 2011;20(9):965-71.
2011: Mario García-Carrasco; César Jiménez-Hernández; Mario Jimenez Hernandez; Stephanie Voorduin-Ramos; Claudia Mendoza-Pinto; Gloria Ramos-Alvarez; Alvaro Montiel-Jarquin; Jorge Rojas-Rodríguez; Ricard Cervera
Susac's syndrome: an update.
Autoimmunity reviews 2011;10(9):548-52.
2011: Mario Garciá-Carrasco; Mario Jimenez Hernandez; Aurelio Lopez-Colombo; Claudia Mendoza-Pinto; Alvaro Montiel-Jarquín; Arnulfo Nava; Carlos Riebeling; Manuel Sandoval-Cruz; Ivet Etchegaray-Morales; Ricard Cervera
Influence of prevalent vertebral fractures on the quality of life of patients with systemic lupus erythematosus.
The Israel Medical Association journal : IMAJ 2011;13(6):333-7.
2011: Xavier Bosch; Francisco Lozano; Ricard Cervera; Manuel Ramos-Casals; Booki Min
Basophils, IgE, and autoantibody-mediated kidney disease.
Journal of immunology (Baltimore, Md. : 1950) 2011;186(11):6083-90.
2011: Ricard Cervera
'ASIA': a new systemic autoimmune syndrome?
Lupus 2011;20(7):665-6.
2011: Gerard Espinosa; Vicente Fonollosa; Xavier Muñoz; Miguel Ángel Plasín; Carmen Pilar Simeón; Ricard Cervera; Antoni Xaubet; Miquel Vilardell
Efficacy of cyclophospamide in the treatment of interstitial lung disease associated with systemic sclerosis.
Archivos de bronconeumología 2011;47(5):239-45.
2011: Ricard Cervera; M G Tektonidou; Gerard Espinosa; A R Cabral; E B González; Doruk Erkan; S Vadya; H E Adrogué; M Solomon; G Zandman-Goddard; Yehuda Shoenfeld
Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations.
Lupus 2011;20(2):174-81.
2011: Ricard Cervera; M G Tektonidou; Gerard Espinosa; A R Cabral; E B González; Doruk Erkan; S Vadya; H E Adrogué; M Solomon; G Zandman-Goddard; Yehuda Shoenfeld
Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions.
Lupus 2011;20(2):165-73.
2011: N Agmon-Levin; Miri Blank; Gisele Zandman-Goddard; H Orbach; P L Meroni; Angela Tincani; A Doria; Ricard Cervera; W Miesbach; Ljudmila Stojanovich; Vivian Barak; B S Porat-Katz; Howard Amital; Yehuda Shoenfeld
Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression.
Annals of the rheumatic diseases 2011;70(1):145-50.
2010: Gerard Espinosa; Ricard Cervera
Belimumab, a BLyS-specific inhibitor for the treatment of systemic lupus erythematosus.
Drugs of today (Barcelona, Spain : 1998) 2010;46(12):891-9.
2010: Ricard Cervera; Gerard Espinosa
Antiphospholipid syndrome: long-time research on pathogenic mechanisms has finally lead to new therapeutic strategies.
Expert opinion on therapeutic targets 2010;14(12):1279-82.
2010: Frédéric A Houssiau; David D'Cruz; Shirish Sangle; Philippe Remy; carlos vasconcelos; Radmila Petrovic; Christoph Fiehn; Enrique de Ramon Garrido; Inge-Magrethe Gilboe; Maria Tektonidou; Daniel Blockmans; Isabelle Ravelingien; Véronique le Guern; Geneviève Depresseux; Loïc Guillevin; Ricard Cervera
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.
Annals of the rheumatic diseases 2010;69(12):2083-9.
2010: George Bertsias; John Ioannidis; M Aringer; E Bollen; Stefano Bombardieri; I N Bruce; Ricard Cervera; M Dalakas; A Doria; J G Hanly; T W J Huizinga; D Isenberg; Cees G M Kallenberg; J C Piette; M Schneider; N Scolding; J Smolen; A Stara; Ioannis Tassiulas; M Tektonidou; Angela Tincani; M A van Buchem; R van Vollenhoven; M Ward; C Gordon; Dimitrios T Boumpas
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs.
Annals of the rheumatic diseases 2010;69(12):2074-82.
2010: Ricard Cervera; Juan Balasch
Autoimmunity and recurrent pregnancy losses.
Clinical reviews in allergy & immunology 2010;39(3):148-52.
2010: M Angeles Martínez-Zamora; Dolors Tassies; Francisco Carmona; Gerard Espinosa; Ricard Cervera; Joan Carles Reverter; Juan Balasch
Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsia with or without associated antiphospholipid antibodies.
Journal of reproductive immunology 2010;86(2):133-40.
2010: Gerardo Quintana; Paola Coral-Alvarado; Gustavo Aroca; Paul Mendez Patarroyo; Philippe Chalem; Antonio Iglesias Gamarra; Ariel Ivan Ruiz; Ricard Cervera
Single anti-P ribosomal antibodies are not associated with lupus nephritis in patients suffering from active systemic lupus erythematosus.
Autoimmunity reviews 2010;9(11):750-5.
2010: Ernesto Cairoli; Gerard Espinosa; Ricard Cervera
[Biological therapies in systemic lupus erythematosus].
Revista médica de Chile 2010;138(7):881-7.
2010: Gerard Espinosa; Ricard Cervera
Antiphospholipid syndrome: frequency, main causes and risk factors of mortality.
Nature reviews. Rheumatology 2010;6(5):296-300.
2010: Ricard Cervera
Catastrophic antiphospholipid syndrome (CAPS): update from the 'CAPS Registry'.
Lupus 2010;19(4):412-8.
2010: Ricard Cervera
Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome.
Current rheumatology reports 2010;12(1):70-6.
2010: Claudia Mendoza-Pinto; Mario García-Carrasco; Mario Jimenez Hernandez; Cesar Jiménez Hernández; Carlos Riebeling-Navarro; Arnulfo Nava; Mauricio Vera Recabarren; Gerard Espinosa; Javier Jara Quezada; Ricard Cervera
Etiopathogenesis of Behcet's disease.
Autoimmunity reviews 2010;9(4):241-5.
2010: Gerard Espinosa; Andrea Mendizábal; Sonia Mínguez; Cristina Ramo-Tello; Jaume Capellades; Alejandro Olivé; Ricard Cervera
Transverse myelitis affecting more than 4 spinal segments associated with systemic lupus erythematosus: clinical, immunological, and radiological characteristics of 22 patients.
Seminars in arthritis and rheumatism 2010;39(4):246-56.
2010: Ricard Cervera
[Therapeutic strategies in antiphospholipid syndrome].
Reumatología clinica 2010;6(1):37-42.
2010: Gerard Espinosa; Ricard Cervera
Recent trends in the management of antiphospholipid syndrome (Hughes syndrome).
Drugs of today (Barcelona, Spain : 1998) 2010;46(1):39-47.
2010: Frédéric A Houssiau; carlos vasconcelos; David D'Cruz; gian domenico sebastiani; Enrique de Ramon Garrido; Maria Giovanna Danieli; D Abramovicz; Daniel Blockmans; A Cauli; Haner Direskeneli; Mauro Galeazzi; A Gül; Y Levy; P Petera; Rajko Popovic; Radmila Petrovic; renato alberto sinico; R Cattaneo; Josep Font; Geneviève Depresseux; Jean-Pierre Cosyns; Ricard Cervera
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide.
Annals of the rheumatic diseases 2010;69(1):61-4.
2009: Maria Angeles Martinez-Zamora; Dolors Tassies; Francisco Carmona; Gerard Espinosa; Ricard Cervera; Joan Carles Reverter; Juan Balasch
Thrombin activatable fibrinolysis inhibitor and clot lysis time in pregnant patients with antiphospholipid syndrome: relationship with pregnancy outcome and thrombosis.
American journal of reproductive immunology (New York, N.Y. : 1989) 2009;62(6):381-9.
2009: H Zinger; Yaniv Sherer; G Goddard; Yackov Berkun; O Barzilai; N Agmon-Levin; M Ram; Miri Blank; Angela Tincani; Blaz Rozman; Ricard Cervera; Yehuda Shoenfeld
Common infectious agents prevalence in antiphospholipid syndrome.
Lupus 2009;18(13):1149-53.
2009: Silvia Bucciarelli; Gerard Espinosa; Ricard Cervera
The CAPS Registry: morbidity and mortality of the catastrophic antiphospholipid syndrome.
Lupus 2009;18(10):905-12.
2009: Ricard Cervera; M-C Boffa; M A Khamashta; G R V Hughes
The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe.
Lupus 2009;18(10):889-93.
2009: Ricard Cervera; M A Khamashta; G R V Hughes
The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe.
Lupus 2009;18(10):869-74.
2009: Ricard Cervera; Angela Tincani
European Working Party on systemic lupus erythematosus and European Forum on Antiphospholipid Antibodies: two networks promoting European research on autoimmunity.
Lupus 2009;18(10):863-8.
2009: Gerard Espinosa; Ricard Cervera
Morbidity and mortality in the antiphospholipid syndrome.
Current opinion in pulmonary medicine 2009;15(5):413-7.
2009: Mario García-Carrasco; Claudia Mendoza-Pinto; Ricardo O Escárcega; Mario Jimenez Hernandez; Ivet Etchegaray Morales; Pamela Munguía Realpozo; Jaime Rebollo-Vázquez; Elena Soto-Vega; Margarita Delezé; Ricard Cervera
Osteoporosis in patients with systemic lupus erythematosus.
The Israel Medical Association journal : IMAJ 2009;11(8):486-91.
2009: Isabel Lázaro; Francisco Carmona; Joan Carles Reverter; Ricard Cervera; Dolors Tassies; Juan Balasch
Antiphospholipid antibodies may impair factor XIIa-dependent activation of fibrinolysis in pregnancy: in vitro evidence with human endothelial cells in culture and monoclonal anticardiolipin antibodies.
American journal of obstetrics and gynecology 2009;201(1):87.e1-6.
2009: Mario García-Carrasco; Claudio Galarza-Maldonado; Claudia Mendoza-Pinto; Ricardo O Escarcega; Ricard Cervera
Infections and the antiphospholipid syndrome.
Clinical reviews in allergy & immunology 2009;36(2-3):104-8.
2009: Silvia Bucciarelli; Doruk Erkan; Gerard Espinosa; Ricard Cervera
Catastrophic antiphospholipid syndrome: treatment, prognosis, and the risk of relapse.
Clinical reviews in allergy & immunology 2009;36(2-3):80-4.
2009: Ricard Cervera; Silvia Bucciarelli; Miguel A Plasín; José A Gómez-Puerta; Joan Plaza; Guillermo Pons-Estel; Yehuda Shoenfeld; Miguel Ingelmo; Gerard Espinos
Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry".
Journal of autoimmunity 2009;32(3-4):240-5.
2009: Claudia Mendoza-Pinto; Mario García-Carrasco; Hilda Sandoval-Cruz; Margarita Muñoz-Guarneros; Ricardo O Escárcega; Mario Jimenez Hernandez; Pamela Munguía-Realpozo; Manuel Sandoval-Cruz; Margarita Delezé-Hinojosa; Aurelio Lopez-Colombo; Ricard Cervera
Risk factors of vertebral fractures in women with systemic lupus erythematosus.
Clinical rheumatology 2009;28(5):579-85.
2009: George Bertsias; John Ioannidis; J Boletis; Stefano Bombardieri; Ricard Cervera; C Dostal; J Font; I M Gilboe; F Houssiau; T Huizinga; D Isenberg; C G M Kallenberg; Munther A Khamashta; J C Piette; M Schneider; J Smolen; G Sturfelt; Angela Tincani; R van Vollenhoven; Dimitrios T Boumpas; C Gordon
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints.
Annals of the rheumatic diseases 2009;68(4):477-83.
2009: Gerard Espinosa; Ricard Cervera
Thromboprophylaxis and obstetric management of the antiphospholipid syndrome.
Expert opinion on pharmacotherapy 2009;10(4):601-14.
2009: Gloria de la Red; Dolors Tàssies; Gerard Espinosa; Joan Monteagudo; Albert Bové; Joan Plaza; Ricard Cervera; Joan Carles Reverter
Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
Thrombosis and haemostasis 2009;101(2):312-6.
2009: Mario García-Carrasco; Mario Jimenez Hernandez; Ricardo O Escárcega; Claudia Mendoza-Pinto; Claudio Galarza-Maldonado; Manuel Sandoval-Cruz; Leticia Zamudio-Huerta; Aurelio Lopez-Colombo; Ricard Cervera
Use of rituximab in patients with systemic lupus erythematosus: an update.
Autoimmunity reviews 2009;8(4):343-8.
2009: José A Gómez-Puerta; Gerard Espinosa; R Morlà; Maria C Cid; Ricard Cervera
Interstitial lung disease as a presenting manifestation of microscopic polyangiitis successfully treated with mycophenolate mofetil.
Clinical and experimental rheumatology 2009;27(1):166-7.
2009: José A Gómez-Puerta; Ricard Cervera; Concepción Moll; Manel Solé; Antonio Collado; Raimon Sanmartí
Proliferative lupus nephritis in a patient with systemic lupus erythematosus and longstanding secondary amyloid nephropathy.
Clinical rheumatology 2009;28(1):95-7.
2009: Claudia Mendoza-Pinto; Mario García-Carrasco; Hilda Sandoval-Cruz; Ricardo O Escárcega; Mario Jimenez Hernandez; Ivet Etchegaray-Morales; Elena Soto-Vega; Margarita Muñoz-Guarneros; Aurelio Lopez-Colombo; Margarita Delezé-Hinojosa; Ricard Cervera
Risks factors for low bone mineral density in pre-menopausal Mexican women with systemic lupus erythematosus.
Clinical rheumatology 2009;28(1):65-70.
2008: Tadej Avcin; Rolando Cimaz; Earl D Silverman; Ricard Cervera; Marco Gattorno; Stella Garay; Yackov Berkun; Flavio R Sztajnbok; Clovis A Silva; Lucia M Campos; Claudia Saad-Magalhaes; Donato Rigante; Angelo Ravelli; Alberto Martini; Blaz Rozman; Pier Luigi Meroni
Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry.
Pediatrics 2008;122(5):e1100-7.
2008: Yehuda Shoenfeld; Ricard Cervera
Asherson's syndrome of the catastrophic antiphospholipid antibodies.
The Journal of rheumatology 2008;35(10):2066-8.
2008: Mario García-Carrasco; Mario Jimenez Hernandez; Ricardo O Escárcega; Claudia Mendoza-Pinto; Rodrigo Pardo-Santos; Roger Levy; Claudio Galarza Maldonado; Gonzalo Pérez Chávez; Ricard Cervera
Treatment of Raynaud's phenomenon.
Autoimmunity reviews 2008;8(1):62-8.
2008: Ronald A Asherson; Ricard Cervera; Evandro Klumb; Ljudmila Stojanovic; Piercarlo Sarzi Puttini; Janet Yinh; Silvia Bucciarelli; Gerard Espinosa; Roger Levy; Yehuda Shoenfeld
Amputation of digits or limbs in patients with antiphospholipid syndrome.
Seminars in arthritis and rheumatism 2008;38(2):124-31.
2008: José A Gómez-Puerta; Rufus W Burlingame; Ricard Cervera
Anti-chromatin (anti-nucleosome) antibodies: diagnostic and clinical value.
Autoimmunity reviews 2008;7(8):606-11.
2008: Ricard Cervera; Ronald A Asherson
Catastrophic antiphospholipid (Asherson's) syndrome.
British journal of hospital medicine (London, England : 2005) 2008;69(7):384-7.
2008: Ricard Cervera; Juan Balasch
Bidirectional effects on autoimmunity and reproduction.
Human reproduction update 2008;14(4):359-66.
2008: D-C Varela; Gerardo Quintana; Emily Somers; Adriana Rojas-Villarraga; G Espinosa; M-E Hincapie; W Joseph McCune; Ricard Cervera; Juan-Manuel Anaya
Delayed lupus nephritis.
Annals of the rheumatic diseases 2008;67(7):1044-6.
2008: Rossana Mejía-Romero; Mario García-Carrasco; Claudio Galarza-Maldonado; Pedro Santos; Claudia Mendoza-Pinto; Ricardo O Escárcega; Salvador Salinas-Saldivar; Elena Soto-Vega; Aurelio Lopez-Colombo; Ricard Cervera
Primary antiphospholipid syndrome in Latin American mestizo patients: clinical and immunologic characteristics and comparison with European patients.
Clinical rheumatology 2008;27(7):891-7.
2008: Ronald A Asherson; Gerard Espinosa; Solomon Menahem; Janet Yinh; Silvia Bucciarelli; Xavier Bosch; Ricard Cervera
Relapsing catastrophic antiphospholipid syndrome: report of three cases.
Seminars in arthritis and rheumatism 2008;37(6):366-72.
2008: Sònia Jiménez; D Tàssies; Gerard Espinosa; Angeles García-Criado; J Plaza; Joan Monteagudo; Ricard Cervera; Joan Carles Reverter
Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis and arteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus.
Annals of the rheumatic diseases 2008;67(6):835-40.
2008: Gerard Espinosa; Silvia Bucciarelli; Ronald A Asherson; Ricard Cervera
Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death, and prognostic factors.
Seminars in thrombosis and hemostasis 2008;34(3):290-4.
2008: Ronald A Asherson; Ricard Cervera; Joan T Merrill; Doruk Erkan
Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.
Seminars in thrombosis and hemostasis 2008;34(3):256-66.
2008: Yehuda Shoenfeld; Pier Luigi Meroni; Ricard Cervera
Antiphospholipid syndrome dilemmas still to be solved: 2008 status.
Annals of the rheumatic diseases 2008;67(4):438-42.
2008: George Bertsias; John Ioannidis; J Boletis; Stefano Bombardieri; Ricard Cervera; C Dostal; J Font; I M Gilboe; F Houssiau; T Huizinga; D Isenberg; Cees G M Kallenberg; Munther A Khamashta; J C Piette; M Schneider; J Smolen; G Sturfelt; Angela Tincani; R van Vollenhoven; C Gordon; Dimitrios T Boumpas
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.
Annals of the rheumatic diseases 2008;67(2):195-205.
2008: Gerard Espinosa; Ricard Cervera
Antiphospholipid syndrome.
Arthritis research & therapy 2008;10(6):230.
2008: gian domenico sebastiani; Gabriella Morozzi; Francesca Bellisai; Irene Fineschi; Maria Romana Bacarelli; Antonella Simpatico; Josep Font; Ricard Cervera; Frederic Houssiau; Antonio Fernandez-Nebro; Enrique de Ramon Garrido; Ornella De Pità; Josef Smolen; Mauro Galeazzi
Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations.
Immunological investigations 2008;37(4):375-85.
2008: Ricard Cervera
Lessons from the "Euro-Phospholipid" project.
Autoimmunity reviews 2008;7(3):174-8.
2008: Ronald A Asherson; Ricard Cervera
Microvascular and microangiopathic antiphospholipid-associated syndromes ("MAPS"): semantic or antisemantic?
Autoimmunity reviews 2008;7(3):164-7.
2007: Wolfgang Miesbach; Ronald A Asherson; Ricard Cervera; Y Shoenfeld; J Gomez Puerta; Gerard Espinosa; Silvia Bucciarelli
The role of malignancies in patients with catastrophic anti-phospholipid (Asherson's) syndrome.
Clinical rheumatology 2007;26(12):2109-14.
2007: Ronald A Asherson; Sylvia Pierangeli; Ricard Cervera
Microangiopathic antiphospholipid-associated syndromes revisited new concepts relating to antiphospholipid antibodies and syndromes.
The Journal of rheumatology 2007;34(9):1793-5.
2007: Mario García-Carrasco; Ricardo O Escárcega; Claudia Mendoza-Pinto; Alfonso Zamora-Ustaran; Ivet Etchegaray-Morales; Jorge Rojas-Rodriguez; Luis E Escobar-Linares; Ricard Cervera
Preventing death in the catastrophic antiphospholipid (Asherson) syndrome.
The Israel Medical Association journal : IMAJ 2007;9(8):628-9.
2007: Yehuda Shoenfeld; Ricard Cervera; Michael Haass; Cees G M Kallenberg; Munther A Khamashta; Pierluigi Meroni; Jean-Charles Piette; Reinhold Schmidt; Allan Wiik
EASI - The European Autoimmunity Standardisation Initiative: a new initiative that can contribute to agreed diagnostic models of diagnosing autoimmune disorders throughout Europe.
Annals of the New York Academy of Sciences 2007;1109():138-44.
2007: I Fuertes; G Espinosa; Manuel Ramos-Casals; Ricard Cervera
[Association of Sjögren syndrome, autoimmune thyroiditis, sarcoidosis, primary biliary cirrhosis and primary amyloidosis in a single patient].
Revista clínica española 2007;207(7):376.
2007: Miri Blank; Liat Anafi; Gisele Zandman-Goddard; Ilan Krause; Shlomit Goldman; eliezer shalev; Ricard Cervera; Josep Font; Mati Fridkin; Hans-Jurgen Thiesen; Yehuda Shoenfeld
The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model.
International immunology 2007;19(7):857-65.
2007: Ronald A Asherson; Ricard Cervera; Yehuda Shoenfeld
Peripheral vascular occlusions leading to gangrene and amputations in antiphospholipid antibody positive patients.
Annals of the New York Academy of Sciences 2007;1108():515-29.
2007: Irit Krause; Miri Blank; Ricard Cervera; J Font; Torsten Matthias; S Pfeiffer; I Wies; Abigail Fraser; Yehuda Shoenfeld
Cross-reactive epitopes on beta2-glycoprotein-I and Saccharomyces cerevisiae in patients with the antiphospholipid syndrome.
Annals of the New York Academy of Sciences 2007;1108():481-8.
2007: Ricard Cervera; Silvia Bucciarelli; Gerard Espinosa; José A Gómez-Puerta; Manuel Ramos-Casals; Yehuda Shoenfeld; Jean-Charles Piette; Ronald A Asherson
Catastrophic antiphospholipid syndrome: lessons from the "CAPS Registry"--a tribute to the late Josep Font.
Annals of the New York Academy of Sciences 2007;1108():448-56.
2007: Mario García-Carrasco; Ricardo O Escárcega; Salvador Fuentes-Alexandro; Carlos Riebeling; Ricard Cervera
Therapeutic options in autoimmune myasthenia gravis.
Autoimmunity reviews 2007;6(6):373-8.
2007: José A Gómez-Puerta; Ricard Cervera; Gerard Espinosa; Ronald A Asherson; Mario García-Carrasco; Izaias P da Costa; Danieli C O Andrade; Eduardo F Borba; Alexander Makatsaria; Silvia Bucciarelli; Manuel Ramos-Casals; Josep Font
Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases.
Annals of the rheumatic diseases 2007;66(6):740-6.
2007: Ricard Cervera; Ronald A Asherson
Catastrophic antiphospholipid syndrome: therapeutic developments.
Expert review of clinical immunology 2007;3(3):277-85.
2007: Gerard Espinosa; Ricard Cervera; Ronald A Asherson
Catastrophic antiphospholipid syndrome and sepsis. A common link?
The Journal of rheumatology 2007;34(5):923-6.
2007: Ronald A Asherson; Ricard Cervera
Pulmonary hypertension, antiphospholipid antibodies, and syndromes.
Clinical reviews in allergy & immunology 2007;32(2):153-8.
2007: Ricard Cervera; Gerard Espinosa
Lupus around the world.
Acta reumatológica portuguesa 2007;32(2):99-101.
2007: Ronald A Asherson; Sylvia S Pierangeli; Ricard Cervera
Is there a microangiopathic antiphospholipid syndrome?
Annals of the rheumatic diseases 2007;66(4):429-32.
2007: Ricard Cervera; Gerard Espinosa; Aida Cordero; M Rosa Oltra; Ainhoa Unzurrunzaga; Tomeu Rossiñol; Joan Plaza; Silvia Bucciarelli; Manuel Ramos-Casals; Miguel Ingelmo; Ronald A Asherson; Josep Font
Intestinal involvement secondary to the antiphospholipid syndrome (APS): clinical and immunologic characteristics of 97 patients: comparison of classic and catastrophic APS.
Seminars in arthritis and rheumatism 2007;36(5):287-96.
2007: Gerard Espinosa; Ricard Cervera
[Role of biologic therapy in systemic autoimmune diseases].
Medicina clínica 2007;128(12):456-7.
2007: Josep Font; Ricard Cervera
[What to do to improve the survival of patients with systemic lupus erythematosus?].
Medicina clínica 2007;128(3):95-6.
2007: Mario García-Carrasco; C Galarza; M Gómez-Ponce; Ricard Cervera; Jorge Rojas-Rodríguez; Gerard Espinosa; Silvia Bucciarelli; José A Gómez-Puerta; Albert Bové; Ricardo O Escárcega; Josep Font
Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients.
Lupus 2007;16(5):366-73.
2007: Mario García-Carrasco; Ricardo O Escárcega; J Pérez-Terrón; A Ramírez; M Muñoz-Guarneros; A Beltrán; B Pérez-Cuevas; Aurelio Lopez-Colombo; Ricard Cervera
Lack of subclinical myocardial ischaemia in Mexican patients with systemic lupus erythematosus without traditional risk factors for coronary artery disease.
Lupus 2007;16(4):298-301.
2007: N Schwartz; Yehuda Shoenfeld; O Barzilai; Ricard Cervera; J Font; Miri Blank; Sarah Yacobi; Natan Patlas; A Cohen; Dror Mevorach; Asher Ornoy
Reduced placental growth and hCG secretion in vitro induced by antiphospholipid antibodies but not by anti-Ro or anti-La: studies on sera from women with SLE/PAPS.
Lupus 2007;16(2):110-20.
2006: Wolfgang Miesbach; Ronald A Asherson; Ricard Cervera; Y Shoenfeld; J Gomez Puerta; Silvia Bucciarelli; G Espinoza; Josep Font
The catastrophic antiphospholipid (Asherson's) syndrome and malignancies.
Autoimmunity reviews 2006;6(2):94-7.
2006: José A Gómez-Puerta; Ricard Cervera; Gerard Espinosa; Silvia Bucciarelli; Josep Font
Pregnancy and puerperium are high susceptibility periods for the development of catastrophic antiphospholipid syndrome.
Autoimmunity reviews 2006;6(2):85-8.
2006: Ricard Cervera; Gerard Espinosa; Silvia Bucciarelli; José A Gómez-Puerta; Josep Font
Lessons from the catastrophic antiphospholipid syndrome (CAPS) registry.
Autoimmunity reviews 2006;6(2):81-4.
2006: Silvia Bucciarelli; Ricard Cervera; Gerard Espinosa; José A Gómez-Puerta; Manuel Ramos-Casals; Josep Font
Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors.
Autoimmunity reviews 2006;6(2):72-5.
2006: Gerard Espinosa; Silvia Bucciarelli; Ricard Cervera; José A Gómez-Puerta; Josep Font
Laboratory studies on pathophysiology of the catastrophic antiphospholipid syndrome.
Autoimmunity reviews 2006;6(2):68-71.
2006: Ricardo O Escárcega; Mario García-Carrasco; Salvador Fuentes-Alexandro; Luis J Jara; Jorge Rojas-Rodriguez; Luis E Escobar-Linares; Ricard Cervera
Insulin resistance, chronic inflammatory state and the link with systemic lupus erythematosus-related coronary disease.
Autoimmunity reviews 2006;6(1):48-53.
2006: Yehuda Shoenfeld; Howard Carp; Vered Molina Hazan (Molina); Miri Blank; Ricard Cervera; Juan Balasch; Angela Tincani; David Faden; Andrea Lojacono; Andrea Doria; Emiliana Konova; Pier Luigi Meroni
Autoantibodies and prediction of reproductive failure.
American journal of reproductive immunology (New York, N.Y. : 1989) 2006;56(5-6):337-44.
2006: Mario García-Carrasco; Salvador Fuentes-Alexandro; Ricardo O Escárcega; Gonzalo Salgado; Carlos Riebeling; Ricard Cervera
Pathophysiology of Sjögren's syndrome.
Archives of medical research 2006;37(8):921-32.
2006: Ricard Cervera; Josep Font; Yehuda Shoenfeld
European Working Party on Systemic Lupus Erythematosus: a 15-year report.
Autoimmunity reviews 2006;5(8):549-53.
2006: Ricard Cervera; Josep Font; Angela Tincani; Marie-Claire Boffa
V meeting of the European forum on antiphospholipid antibodies.
Autoimmunity reviews 2006;5(7):499-507.
2006: Ricard Cervera; Ronald A Asherson; Josep Font
Catastrophic antiphospholipid syndrome.
Rheumatic diseases clinics of North America 2006;32(3):575-90.
2006: Silvia Bucciarelli; Gerard Espinosa; Ricard Cervera; Doruk Erkan; José A Gómez-Puerta; Manuel Ramos-Casals; Josep Font; Ronald A Asherson
Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients.
Arthritis and rheumatism 2006;54(8):2568-76.
2006: José A Gómez-Puerta; Gerard Espinosa; José M Miró; Omar Sued; Josep M Llibre; Ricard Cervera; Josep Font
Behçet's disease in an HIV-1-infected patient treated with highly active antiretroviral therapy.
The Israel Medical Association journal : IMAJ 2006;8(7):513-4.
2006: Ronald A Asherson; Ricard Cervera; Daniel Shepshelovich; Yehuda Shoenfeld
Nonthrombotic manifestations of the antiphospholipid syndrome: away from thrombosis?
The Journal of rheumatology 2006;33(6):1038-44.
2006: Norma Nardi; Pilar Brito-Zerón; Manuel Ramos-Casals; Sira Aguiló; Ricard Cervera; Miguel Ingelmo; Josep Font
Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjögren's syndrome: prevalence and clinical significance in 335 patients.
Clinical rheumatology 2006;25(3):341-6.
2006: Ricard Cervera; Ronald A Asherson
Primary pulmonary arterial hypertension and the systemic autoimmune diseases.
The Israel Medical Association journal : IMAJ 2006;8(4):277-9.
2006: José A Gómez-Puerta; Ricard Cervera; Gerard Espinosa; Sira Aguiló; Silvia Bucciarelli; Manuel Ramos-Casals; Miguel Ingelmo; Ronald A Asherson; Josep Font
Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients.
Seminars in arthritis and rheumatism 2006;35(5):322-32.
2006: Manuel Ramos-Casals; Norma Nardi; Mariana Lagrutta; Pilar Brito-Zerón; Albert Bové; German Delgado; Ricard Cervera; Miguel Ingelmo; Josep Font
Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients.
Medicine 2006;85(2):95-104.
2006: Ricard Cervera; M Abarca-Costalago; D Abramovicz; F Allegri; P Annunziata; A O Aydintug; M R Bacarelli; F Bellisai; I Bernardino; E Biernat-Kaluza; D Blockmans; K Boki; Luisa Bracci; V Campanella; M T Camps; C Carcassi; R Cattaneo; A Cauli; R Cervera; H Chwalinska-Sadowska; L Contu; J P Cosyns; M G Danieli; D DCruz; G Depresseux; H Direskeneli; I Domènech; G Espinosa; A Fernández-Nebro; G B Ferrara; J Font; M A Frutos; M Galeazzi; M Garcìa-Carrasco; M F García Iglesias; A García-Tobaruela; J George; A Gil; P González-Santos; M Grana; A Gül; H J Haga; M de Haro-Liger; F Houssiau; G R V Hughes; M Ingelmo; A Jedryka-Góral; M A Khamashta; P Lavilla; Y Levi; M López-Dulpa; A López-Soto; H Maldykowa; R Marcolongo; A Mathieu; G Morozzi; N Nicolopoulou; C Papasteriades; G Passiu; I Perelló; P Petera; R Petrovic; J C Piette; V Pintado; O de Pita; R Popovic; G Pucci; P Puddu; E de Ramón; Manuel Ramos-Casals; J Rodríguez-Andreu; G Ruiz-Irastorza; J Sanchez-Lora; G Sanna; R Scorza; gian domenico sebastiani; Y Sherer; Y Shoenfeld; A Simpatico; renato alberto sinico; J Smolen; A Tincani; G Tokgöz; A Urbano-Márquez; carlos vasconcelos; J J Vázquez; J Veronesi; J Vianna; J Vivancos
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project".
Autoimmunity reviews 2006;5(3):180-6.
2006: Francisco Carmona; Isabel Lázaro; Joan Carles Reverter; Dolors Tàssies; Josep Font; Ricard Cervera; Juan Balasch
Impaired factor XIIa-dependent activation of fibrinolysis in treated antiphospholipid syndrome gestations developing late-pregnancy complications.
American journal of obstetrics and gynecology 2006;194(2):457-65.
2006: Spiros Miyakis; M D Lockshin; T Atsumi; D W Branch; Robin Brey; Ricard Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; Steven A Krilis
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).
Journal of thrombosis and haemostasis : JTH 2006;4(2):295-306.
2006: T Rossiñol; Ricard Cervera; C López; M Solé; Manuel Ramos-Casals; J Font
Antiphospholipid syndrome and minimal change nephropathy.
Lupus 2006;15(8):547-8.
2006: José A Gómez-Puerta; R W Burlingame; Ricard Cervera
Anti-chromatin (anti-nucleosome) antibodies.
Lupus 2006;15(7):408-11.
2006: Allan Wiik; Ricard Cervera; M Haass; C Kallenberg; M Khamashta; P L Meroni; J-C Piette; R Schmitt; Y Shoenfeld
European attempts to set guidelines for improving diagnostics of autoimmune rheumatic disorders.
Lupus 2006;15(7):391-6.
2006: Ricard Cervera; Ronald A Asherton
Catastrophic antiphospholipid syndrome.
Pathophysiology of haemostasis and thrombosis 2006;35(1-2):181-6.
2006: J Mundo; Pilar Peris; Ana Monegal; M Navasa; Ricard Cervera; N Guañiabens
Multifocal avascular necrosis after liver transplantation: an unusual presentation of the antiphospholipid syndrome.
Lupus 2006;15(5):304-7.
2006: Monika Østensen; Munther A Khamashta; Michael D Lockshin; Ann Parke; Antonio Brucato; Howard Carp; Andrea Doria; Raj Rai; Pierluigi Meroni; Irene Cetin; Ronald Derksen; Ware Branch; Mario Motta; Caroline Gordon; Guillermo Ruiz-Irastorza; Arsenio Spinillo; Deborah Friedman; Rolando Cimaz; Andrew E Czeizel; Jean Charles Piette; Ricard Cervera; Roger levy; Maurizio Clementi; Sara De Carolis; Michelle Petri; Yehuda Shoenfeld; David Faden; Guido Valesini; Angela Tincani
Anti-inflammatory and immunosuppressive drugs and reproduction.
Arthritis research & therapy 2006;8(3):209.
2006: Jose A. Gomez-Puerta; E Salgado; Ricard Cervera; S Aguilo; Manuel Ramos-Casals; M Soler; A Torras; Josep Font
Catastrophic antiphospholipid syndrome presenting with renal thrombotic microangiopathy and diffuse proliferative glomerulonephritis.
Clinical and experimental rheumatology 2006;24(1):110.
2006: Y Shoenfeld; M Blank; Ricard Cervera; J Font; E Raschi; P-L Meroni
Infectious origin of the antiphospholipid syndrome.
Annals of the rheumatic diseases 2006;65(1):2-6.
2006: Silvia Bucciarelli; Gerard Espinosa; Ronald A Asherson; Ricard Cervera; Gisela Claver; José A Gómez-Puerta; Manuel Ramos-Casals; Miguel Ingelmo
The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients.
Annals of the rheumatic diseases 2006;65(1):81-6.
2005: José A Gómez-Puerta; Jorge Musuruana; Carlos Saez; Ricard Cervera; Josep Font
[Sarcoidosis as seronegative spondyloarthropathy].
Biomédica : revista del Instituto Nacional de Salud 2005;25(4):435-8.
2005: Ricard Cervera; Josep Font; José A Gómez-Puerta; Gerard Espinosa; M Cucho; Silvia Bucciarelli; Manuel Ramos-Casals; Miguel Ingelmo; Jean-Charles Piette; Yehuda Shoenfeld; Ronald A Asherson
Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome.
Annals of the rheumatic diseases 2005;64(8):1205-9.
2005: Gerard Espinosa; Juan I Arostegui; Susana Plaza; Josefa Rius; Ricard Cervera; Jordi Yagüe; Josep Font
Behçet's disease and hereditary periodic fever syndromes: casual association or causal relationship?
Clinical and experimental rheumatology 2005;23(4 Suppl 38):S64-6.
2005: Felix Perez-Villa; Josep Font; Manel Azqueta; Gerard Espinosa; Carles Pare; Ricard Cervera; Joan Carles Reverter; Miguel Ingelmo; Gines Sanz
Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study.
Arthritis and rheumatism 2005;53(3):460-7.
2005: Ronald A Asherson; Gerard Espinosa; Ricard Cervera; José A Gómez-Puerta; J Musuruana; Silvia Bucciarelli; Manuel Ramos-Casals; A L Martínez-González; Miguel Ingelmo; Joan Carles Reverter; Josep Font; Douglas A Triplett
Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients.
Annals of the rheumatic diseases 2005;64(6):943-6.
2005: Sònia Jiménez; M Angels García-Criado; Dolors Tàssies; Joan Carles Reverter; Ricard Cervera; M Rosa Gilabert; Daniel Zambón; Emilio Ros; Concepció Bru; Josep Font
Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome.
Rheumatology (Oxford, England) 2005;44(6):756-61.
2005: Pilar Brito-Zerón; Manuel Ramos-Casals; Norma Nardi; Ricard Cervera; Jordi Yagüe; Miguel Ingelmo; Josep Font
Circulating monoclonal immunoglobulins in Sjögren syndrome: prevalence and clinical significance in 237 patients.
Medicine 2005;84(2):90-7.
2005: Manuel Ramos-Casals; Juan Mañá; Norma Nardi; Pilar Brito-Zerón; Antoni Xaubet; José M Sánchez-Tapias; Ricard Cervera; Josep Font
Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases.
Medicine 2005;84(2):69-80.
2005: Ricard Cervera; Ronald A Asherson
Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics.
Immunobiology 2005;210(10):735-41.
2005: José A Gómez-Puerta; Ricard Cervera; L M Calvo; Beatriz Gómez-Ansón; Gerard Espinosa; Gisela Claver; Silvia Bucciarelli; Albert Bové; Manuel Ramos-Casals; Miguel Ingelmo; Josep Font
Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients.
Rheumatology (Oxford, England) 2005;44(1):95-9.
2004: Frédéric A Houssiau; carlos vasconcelos; David D'Cruz; gian domenico sebastiani; Enrique de Ramon Garrido; Maria Giovanna Danieli; Daniel Abramovicz; Daniel Blockmans; Alessandro Mathieu; Haner Direskeneli; Mauro Galeazzi; Ahmet Gül; Yair Levy; Peter Petera; Rajko Popovic; Radmila Petrovic; renato alberto sinico; Roberto Cattaneo; Josep Font; Geneviève Depresseux; Jean-Pierre Cosyns; Ricard Cervera
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
Arthritis and rheumatism 2004;50(12):3934-40.
2004: Juan Jiménez-Alonso; José Mario Sabio; P L Carrillo-Alascio; J Jiménez-Jáimez; Norberto Ortego Centeno; E Jiménez-Jáimez; C Hidalgo Tenorio; M Guzmán-Ubeda; Laura Jáimez; Rafael Cáliz; A García-Sánchez; M Gallego; L Caminal; José Luis Callejas Rubio; Ricard Cervera; J Font
[Intolerance to hydroxychloroquine marketed in Spain (Dolquine) in patients with autoimmune conditions].
Revista clínica española 2004;204(11):588-91.
2004: Ricard Cervera; Josep Font
[Therapeutical perspectives in systemic lupus erythematosus].
Medicina clínica 2004;123(14):540-2.
2004: Ricard Cervera; Ronald A Asherson; M L Acevedo; José A Gómez-Puerta; Gerard Espinosa; Gloria de la Red; Victor Gil; Manuel Ramos-Casals; Mario García-Carrasco; Miguel Ingelmo; Josep Font
Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients.
Annals of the rheumatic diseases 2004;63(10):1312-7.
2004: Yehuda Shoenfeld; Shaul Lev; Ilan Blatt; Miri Blank; Joseph Font; Philipp von Landenberg; Nirit Lev; Joseph Zaech; Ricard Cervera; Jean-Charles Piette; Munther A Khamashta; Maria L Bertolaccini; Graham R V Hughes; Pierre Youinou; Pierre Luigi Meroni; Vittorio Pengo; J Delgado Alves; Angela Tincani; Gyula Szegedi; Gabriella Lakos; Gunnar Sturfelt; Andreas Jönsen; Takao Koike; Marielle Sanmarco; Amelia Ruffatti; Zdenka Ulcova-Gallova; Sonja Praprotnik; Blaz Rozman; Margalit Lorber; Joab Chapman; Peter J C van-Breda-Vriezman; Jan Damoiseaux
Features associated with epilepsy in the antiphospholipid syndrome.
The Journal of rheumatology 2004;31(7):1344-8.
2004: Gerard Espinosa; Silvia Bucciarelli; Ricard Cervera; M Lozano; Joan Carles Reverter; Gloria de la Red; Victor Gil; Miguel Ingelmo; Josep Font; Ronald A Asherson
Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies.
Annals of the rheumatic diseases 2004;63(6):730-6.
2004: Manuel Ramos-Casals; Ricard Cervera; Mariana Lagrutta; Francisco Medina; Mario García-Carrasco; Gloria de la Red; Albert Bové; Miguel Ingelmo; Josep Font
Clinical features related to antiphospholipid syndrome in patients with chronic viral infections (hepatitis C virus/HIV infection): description of 82 cases.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(7):1009-16.
2004: Manuel Ramos-Casals; Olga Trejo; Mario García-Carrasco; Ricard Cervera; Gloria de la Red; Victor Gil; Armando López-Guillermo; Miguel Ingelmo; Josep Font
Triple association between hepatitis C virus infection, systemic autoimmune diseases, and B cell lymphoma.
The Journal of rheumatology 2004;31(3):495-9.
2004: Josep Font; Ricard Cervera; Manuel Ramos-Casals; Mario García-Carrasco; Juan Sents; Carme Herrero; Jose-Antonio del Olmo; Alexandre Darnell; Miguel Ingelmo
Clusters of clinical and immunologic features in systemic lupus erythematosus: analysis of 600 patients from a single center.
Seminars in arthritis and rheumatism 2004;33(4):217-30.
2004: Manuel Ramos-Casals; Armando López-Guillermo; Pilar Brito-Zerón; Ricard Cervera; Josep Font
Treatment of B-cell lymphoma with rituximab in two patients with Sjögren's syndrome associated with hepatitis C virus infection.
Lupus 2004;13(12):969-71.
2004: Manuel Ramos-Casals; M T Campoamor; A Chamorro; G Salvador; S Segura; J C Botero; Jordi Yagüe; Ricard Cervera; Miguel Ingelmo; Josep Font
Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.
Lupus 2004;13(10):777-83.
2004: Ricard Cervera
Coronary and valvular syndromes and antiphospholipid antibodies.
Thrombosis research 2004;114(5-6):501-7.
2004: Ricard Cervera; Juan Balasch
The management of pregnant patients with antiphospholipid syndrome.
Lupus 2004;13(9):683-7.
2004: Silvia Bucciarelli; Ricard Cervera; M Martínez; Xavier Latorre; Josep Font
Susac's syndrome or catastrophic antiphospholipid syndrome?
Lupus 2004;13(8):607-8.
2004: Miri Blank; R A Asherson; Ricard Cervera; Yehuda Shoenfeld
Antiphospholipid syndrome infectious origin.
Journal of clinical immunology 2004;24(1):12-23.
2004: José A Gómez-Puerta; Victor Gil; Ricard Cervera; R Miquel; S Jiménez; Manuel Ramos-Casals; Josep Font
Coeliac disease associated with systemic sclerosis.
Annals of the rheumatic diseases 2004;63(1):104-5.
2003: Doruk Erkan; Ricard Cervera; Ronald A Asherson
Catastrophic antiphospholipid syndrome: where do we stand?
Arthritis and rheumatism 2003;48(12):3320-7.
2003: Ronald A Asherson; Ricard Cervera
Catastrophic antiphospholipid syndrome.
Current rheumatology reports 2003;5(5):395-400.
2003: Y Shoenfeld; I Krause; F Kvapil; J Sulkes; S Lev; P von Landenberg; J Font; J Zaech; Ricard Cervera; J C Piette; M C Boffa; M A Khamashta; M L Bertolaccini; G R V Hughes; P Youinou; P L Meroni; V Pengo; J D Alves; A Tincani; G Szegedi; Gabriella Lakos; G Sturfelt; A Jönsen; T Koike; M Sanmarco; A Ruffatti; Z Ulcova-Gallova; S Praprotnik; B Rozman; M Lorber; V B Vriezman; M Blank
Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndrome.
Journal of clinical immunology 2003;23(5):377-83.
2003: Jean-Charles Piette; Ricard Cervera; Roger levy; Eugeny L Nasonov; Douglas A Triplett; Yehuda Shoenfeld
The catastrophic antiphospholipid syndrome--Asherson's syndrome.
Annales de médecine interne 2003;154(4):195-6.
2003: Ricard Cervera; Munther A Khamashta; Josep Font; gian domenico sebastiani; Antonio Gil; Paz Lavilla; Juan Carlos Mejía; A Olcay Aydintug; Hanna Chwalinska-Sadowska; Enrique de Ramón; Antonio Fernández-Nebro; Mauro Galeazzi; Merete Valen; Alessandro Mathieu; Frédéric A Houssiau; Natividad Caro; Paula Alba; Manuel Ramos-Casals; Miguel Ingelmo; G R V Hughes
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.
Medicine 2003;82(5):299-308.
2003: Olga Trejo; Manuel Ramos-Casals; Armando López-Guillermo; Mario García-Carrasco; Jordi Yagüe; Ricard Cervera; Josep Font; Miguel Ingelmo
Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases.
Seminars in arthritis and rheumatism 2003;33(1):19-28.
2003: Ronald A Asherson; Ricard Cervera
Unusual manifestations of the antiphospholipid syndrome.
Clinical reviews in allergy & immunology 2003;25(1):61-78.
2003: Sònia Jiménez; Ricard Cervera; Josep Font; Miguel Ingelmo
The epidemiology of systemic lupus erythematosus.
Clinical reviews in allergy & immunology 2003;25(1):3-12.
2003: Josep Font; Manuel Ramos-Casals; Gloria de la Red; Adolf Pou; Arnau Casanova; Mario García-Carrasco; Ricard Cervera; José A Molina; Josep Valls; Albert Bové; Miguel Ingelmo; Francesc Graus
Pure sensory neuropathy in primary Sjögren's syndrome. Longterm prospective followup and review of the literature.
The Journal of rheumatology 2003;30(7):1552-7.
2003: Doruk Erkan; R A Asherson; G Espinosa; Ricard Cervera; J Font; J-C Piette; Michael D Lockshin
Long term outcome of catastrophic antiphospholipid syndrome survivors.
Annals of the rheumatic diseases 2003;62(6):530-3.
2003: Ronald A Asherson; Ricard Cervera
The antiphospholipid syndrome: multiple faces beyond the classical presentation.
Autoimmunity reviews 2003;2(3):140-51.
2003: Ricard Cervera; Octavi Viñas; Manuel Ramos-Casals; Josep Font; Mario García-Carrasco; Antoni Sisó Almirall; F Ramírez; Y Machuca; Jordi Vives; Miguel Ingelmo; R W Burlingame
Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy.
Annals of the rheumatic diseases 2003;62(5):431-4.
2003: Ronald A Asherson; Ricard Cervera
Antiphospholipid antibodies and infections.
Annals of the rheumatic diseases 2003;62(5):388-93.
2003: José A Gómez-Puerta; Victor Gil; Ricard Cervera
"Catastrophic" antiphospholipid syndrome.
Mayo Clinic proceedings. Mayo Clinic 2003;78(4):519; author reply 519, 521.
2003: Gerard Espinosa; Ricard Cervera; Josep Font; Yehuda Shoenfeld
Antiphospholipid syndrome: pathogenic mechanisms.
Autoimmunity reviews 2003;2(2):86-93.
2003: C Miret; F Nonell; Ricard Cervera; E Rodríguez-Flores; M Torres
IgA nephropathy associated with eosinophilic fasciitis: report of a case.
Clinical and experimental rheumatology 2003;21(2):268.
2003: Gerard Espinosa; Eugénia Santos; Ricard Cervera; Jean-Charles Piette; Gloria de la Red; Victor Gil; Josep Font; Robert Couch; Miguel Ingelmo; Ronald A Asherson
Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients.
Medicine 2003;82(2):106-18.
2003: M Rifé; Cèlia Badenas; J Mallolas; L Jiménez; Ricard Cervera; A Maya; G Glover; F Rivera; Montserrat Milà
Incidence of fragile X in 5,000 consecutive newborn males.
Genetic testing 2003;7(4):339-43.
2003: Gerard Espinosa; Ricard Cervera; Josep Font; Ronald A Asherson
Adrenal involvement in the antiphospholipid syndrome.
Lupus 2003;12(7):569-72.
2003: gian domenico sebastiani; Mauro Galeazzi; Angela Tincani; Raffaella Scorza; Alessandro Mathieu; Giuseppe Passiu; Gabriella Morozzi; Jean-Charles Piette; Ricard Cervera; Frédéric A Houssiau; Josef Smolen; Antonio Fernandez-Nebro; E De Ramon; A Jedryka Goral; Chryssa Papasteriades; Giovanni Battista Ferrara; Carlo Carcassi; Francesca Bellisai; Roberto Marcolongo
HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus.
Lupus 2003;12(7):560-3.
2003: R A Asherson; Ricard Cervera; P G de Groot; D Erkan; M C Boffa; J C Piette; M A Khamashta; Y Shoenfeld
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines.
Lupus 2003;12(7):530-4.
2003: Donato Alarcón-Segovia; M C Boffa; W Branch; Ricard Cervera; A Gharavi; M Khamashta; Yehuda Shoenfeld; W Wilson; Robert A S Roubey
Prophylaxis of the antiphospholipid syndrome: a consensus report.
Lupus 2003;12(7):499-503.
2003: Ricard Cervera; Ronald A Asherson
Clinical and epidemiological aspects in the antiphospholipid syndrome.
Immunobiology 2003;207(1):5-11.
2002: Ricard Cervera; Josep Font; Francisco Carmona; Juan Balasch
Pregnancy outcome in systemic lupus erythematosus: good news for the new millennium.
Autoimmunity reviews 2002;1(6):354-9.
2002: Rufus W Burlingame; Ricard Cervera
Anti-chromatin (anti-nucleosome) autoantibodies.
Autoimmunity reviews 2002;1(6):321-8.
2002: Ricard Cervera; M Abarca-Costalago; D Abramovicz; F Allegri; P Annunziata; A O Aydintug; M R Bacarelli; F Bellisai; I Bernardino; E Biernat-Kaluza; D Blockmans; K Boki; Luisa Bracci; V Campanella; M T Camps; C Carcassi; R Cattaneo; A Cauli; H Chwalinska-Sadowska; L Contu; J P Cosyns; M G Danieli; D D'Cruz; G Depresseux; H Direskeneli; I Domènech; G Espinosa; A Fernández-Nebro; G B Ferrara; J Font; M A Frutos; M Galeazzi; M García-Carrasco; M F García-Iglesias; A García-Tobaruela; J George; A Gil; P González-Santos; M Grana; A Gül; H J Haga; M de Haro-Liger; F Houssiau; G R V Hughes; M Ingelmo; A Jedryka-Góral; M A Khamashta; P Lavilla; Y Levi; M López-Dupla; A López-Soto; H Maldykowa; R Marcolongo; A Mathieu; G Morozzi; N Nicolopoulou; C Papasteriades; G Passiu; I Perelló; P Petera; R Petrovic; J-C Piette; V Pintado; O de Pita; R Popovic; G Pucci; P Puddu; E de Ramón; Manuel Ramos-Casals; J Rodríguez-Andreu; G Ruiz-Irastroza; J Sánchez-Lora; G Sanna; R Scorza; G D Sebastini; Y Sherer; Y Shoenfeld; A Simpatico; renato alberto sinico; J Smolen; A Tincani; G Tokgöz; A Urbano-Márquez; carlos vasconcelos; J J Vázquez; M Veronesi; J Vianni; J Vivancos
Lessons from the "Euro-Lupus Cohort".
Annales de médecine interne 2002;153(8):530-6.
2002: Josep Font; Gerard Espinosa; Dolors Tàssies; Marc Pino; Munther A Khamashta; Teresa Gallart; Ricard Cervera; Gines Escolar; G R V Hughes; Miguel Ingelmo; Antonio Ordinas; Joan Carles Reverter
Effects of beta2-glycoprotein I and monoclonal anticardiolipin antibodies in platelet interaction with subendothelium under flow conditions.
Arthritis and rheumatism 2002;46(12):3283-9.
2002: Josep Font; Manuel Ramos-Casals; A P Vilas; Mario García-Carrasco; Maria-Pilar Brito; Gloria de la Red; Victor Gil; A García-Carrasco; Ricard Cervera; Miguel Ingelmo
Low values of creatine kinase in systemic lupus erythematosus. Clinical significance in 300 patients.
Clinical and experimental rheumatology 2002;20(6):837-40.
2002: Josep Font; Mario García-Carrasco; Manuel Ramos-Casals; Anna Aldea; Ricard Cervera; Miguel Ingelmo; Jordi Vives; Jordi Yagüe
The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjögren's syndrome.
Rheumatology (Oxford, England) 2002;41(9):1025-30.
2002: Manuel Ramos-Casals; Mario García-Carrasco; Maria Pilar Brito Zerón; Ricard Cervera; Josep Font
Viral etiopathogenesis of Sjögren's syndrome: role of the hepatitis C virus.
Autoimmunity reviews 2002;1(4):238-43.
2002: Manuel Ramos-Casals; Mario García-Carrasco; Ricard Cervera; Xavier Filella; Olga Trejo; Gloria de la Red; Victor Gil; José M Sánchez-Tapias; Josep Font; Miguel Ingelmo
Th1/Th2 cytokine imbalance in patients with Sjögren syndrome secondary to hepatitis C virus infection.
Seminars in arthritis and rheumatism 2002;32(1):56-63.
2002: Frédéric A Houssiau; carlos vasconcelos; David D'Cruz; gian domenico sebastiani; Enrique de Ramon Garrido Ed; Maria Giovanna Danieli; Daniel Abramovicz; Daniel Blockmans; Alessandro Mathieu; Haner Direskeneli; Mauro Galeazzi; Ahmet Gül; Yair Levy; Peter Petera; Rajko Popovic; Radmila Petrovic; renato alberto sinico; Roberto Cattaneo; Josep Font; Geneviève Depresseux; Jean-Pierre Cosyns; Ricard Cervera
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
Arthritis and rheumatism 2002;46(8):2121-31.
2002: Gerard Espinosa; Josep Font; FJ Muñoz-Rodríguez; Ricard Cervera; Miguel Ingelmo
Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship?
Clinical rheumatology 2002;21(4):309-13.
2002: Gerard Espinosa; Ricard Cervera; Joan Carles Reverter; Dolors Tàssies; Josep Font; Miguel Ingelmo
Vascular involvement in Behçet's disease.
The Israel Medical Association journal : IMAJ 2002;4(8):614-6.
2002: Manuel Ramos-Casals; Josep Font; Mario Garcia-Carrasco; Maria-Pilar Brito; José Rosas; Jaime Calvo-Alen; Lucio Pallares; Ricard Cervera; Miguel Ingelmo
Primary Sjögren syndrome: hematologic patterns of disease expression.
Medicine 2002;81(4):281-92.
2002: Mario García-Carrasco; Manuel Ramos-Casals; José Rosas; Lucio Pallarés; Jaime Calvo-Alen; Ricard Cervera; Josep Font; Miguel Ingelmo
Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients.
Medicine 2002;81(4):270-80.
2002: Ronald A Asherson; Gerard Espinosa; Ricard Cervera; Josep Font; Joan Carles Reverter
Catastrophic antiphospholipid syndrome: proposed guidelines for diagnosis and treatment.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2002;8(3):157-65.
2002: J Rosas; Manuel Ramos-Casals; J Ena; Mario García-Carrasco; J Verdu; Ricard Cervera; J Font; O Caballero; M Ingelmo; Eliseo Pascual
Usefulness of basal and pilocarpine-stimulated salivary flow in primary Sjögren's syndrome. Correlation with clinical, immunological and histological features.
Rheumatology (Oxford, England) 2002;41(6):670-5.
2002: Francisco López-Medrano; Ricard Cervera; Olga Trejo; Josep Font; Miguel Ingelmo
Steroid induced psychosis in systemic lupus erythematosus: a possible role of serum albumin level.
Annals of the rheumatic diseases 2002;61(6):562-3.
2002: Mauro Galeazzi; gian domenico sebastiani; Gabriella Morozzi; Carlo Carcassi; Giovanni Battista Ferrara; Raffaella Scorza; Ricard Cervera; Enrique de Ramon Garrido; Antonio Fernandez-Nebro; Frédéric A Houssiau; Anna Jedryka-Goral; Giuseppe Passiu; Chryssa Papasteriades; Jean-Charles Piette; Josef Smolen; Giovanni Porciello; Roberto Marcolongo
HLA class II DNA typing in a large series of European patients with systemic lupus erythematosus: correlations with clinical and autoantibody subsets.
Medicine 2002;81(3):169-78.
2002: Ricard Cervera; Jean-Charles Piette; Josep Font; Munther A Khamashta; Yehuda Shoenfeld; María Teresa Camps; Soren Jacobsen; Gabriella Lakos; Angela Tincani; Irene Kontopoulou-Griva; Mauro Galeazzi; Pier Luigi Meroni; R H W M Derksen; Philip G de Groot; Erika Gromnica-Ihle; Marta Baleva; Marta Mosca; Stefano Bombardieri; Frédéric A Houssiau; Jean-Christophe Gris; Isabelle Quéré; Eric Hachulla; carlos vasconcelos; Beate Roch; Antonio Fernández-Nebro; Marie-Claire Boffa; G R V Hughes; Miguel Ingelmo
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.
Arthritis and rheumatism 2002;46(4):1019-27.
2002: Mario García-Carrasco; Antoni Sisó Almirall; Manuel Ramos-Casals; José Rosas; Gloria de la Red; Victor Gil; Susana Lasterra; Ricard Cervera; Josep Font; Miguel Ingelmo
Raynaud's phenomenon in primary Sjögren's syndrome. Prevalence and clinical characteristics in a series of 320 patients.
The Journal of rheumatology 2002;29(4):726-30.
2002: Teresa Gallart; Carmen Benito; Joan Carles Reverter; Francesc Bosch; Mayte Blay; Dolors Tàssies; Elena Vigorito; Ricard Cervera; Josep Font; Ramon Gomis; Elias Campo; Jordi Vives
True anti-anionic phospholipid immunoglobulin M antibodies can exert lupus anticoagulant activity.
British journal of haematology 2002;116(4):875-86.
2002: Gerard Espinosa; Ricard Cervera; Josep Font; Ronald A Asherson
The lung in the antiphospholipid syndrome.
Annals of the rheumatic diseases 2002;61(3):195-8.
2002: FJ Muñoz-Rodríguez; Joan Carles Reverter; Josep Font; Dolors Tàssies; Gerard Espinosa; Ricard Cervera; Francisco Carmona; J Balsch; Miguel Ingelmo; Antonio Ordinas
Clinical significance of acquired activated protein C resistance in patients with systemic lupus erythematosus.
Lupus 2002;11(11):730-5.
2002: J Balasch; Ricard Cervera
Reflections on the management of reproductive failure in the antiphospholipid syndrome--the clinician's perspective.
Lupus 2002;11(8):467-77.
2002: Gerard Espinosa; Josep Font; Dolors Tàssies; Antonio Vidaller; Ramon Deulofeu; Alfonso López-Soto; Ricard Cervera; Antonio Ordinas; Miguel Ingelmo; Joan Carles Reverter
Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.
The American journal of medicine 2002;112(1):37-43.
2002: G Espinosa; Ricard Cervera; J Font
[The lung in antiphospholipid syndrome].
Archivos de bronconeumología 2002;38(1):27-32.
2001: R A Asherson; Ricard Cervera; J C Piette; Y Shoenfeld; Gerard Espinosa; Michelle Petri; E Lim; T C Lau; A Gurjal; Anna Jedryka-Góral; Hanna Chwalinska-Sadowska; R J Dibner; Jorge Rojas-Rodríguez; Mario García-Carrasco; J T Grandone; A L Parke; P Barbosa; carlos vasconcelos; Manuel Ramos-Casals; Josep Font; Miguel Ingelmo
Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients.
Medicine 2001;80(6):355-77.
2001: Gerard Espinosa; Josep Font; J C García-Pagan; Dolors Tàssies; Joan Carles Reverter; Carles Gaig; Francisco Cervantes; Ricard Cervera; Jaime Bosch; Miguel Ingelmo
Budd-Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients.
Medicine 2001;80(6):345-54.
2001: Francisco Carmona; J Font; M Azulay; Montserrat Creus; Francisco Fábregues; Ricard Cervera; Bienvenido Puerto; Juan Balasch
Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis.
American journal of reproductive immunology (New York, N.Y. : 1989) 2001;46(4):274-9.
2001: Manuel Ramos-Casals; Mario Garcia-Carrasco; Ricard Cervera; Josep Font
Is hepatitis C virus a sialotropic virus?
The American journal of pathology 2001;159(4):1593-4.
2001: Manuel Ramos-Casals; Josep Font; M García-Carrasco; Javier Calvo; Lourdes Places; Olga Padilla; Ricard Cervera; MA Bowen; Francisco Lozano; Miguel Ingelmo
High circulating levels of soluble scavenger receptors (sCD5 and sCD6) in patients with primary Sjögren's syndrome.
Rheumatology (Oxford, England) 2001;40(9):1056-9.
2001: Gerard Espinosa; Dolors Tàssies; Josep Font; FJ Muñoz-Rodríguez; Ricard Cervera; Antonio Ordinas; Joan Carles Reverter; Miguel Ingelmo
Antiphospholipid antibodies and thrombophilic factors in giant cell arteritis.
Seminars in arthritis and rheumatism 2001;31(1):12-20.
2001: Carlos Miret; Josep Font; Rafael Molina; Mario Garcia-Carrasco; Xavier Filella; M Ramos; Ricard Cervera; Antonio M Ballesta; Miguel Ingelmo
Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
Anticancer research 2001;21(4B):3053-9.
2001: M Garcíc-Carrasco; Josep Font; X Filella; Ricard Cervera; Manuel Ramos-Casals; Antoni Sisó Almirall; A Aymamí; A M Ballesta; Miguel Ingelmo
Circulating levels of Th1/Th2 cytokines in patients with primary Sjögren's syndrome: correlation with clinical and immunological features.
Clinical and experimental rheumatology 2001;19(4):411-5.
2001: Olga Trejo; Manuel Ramos-Casals; Mario García-Carrasco; Jordi Yagüe; Sònia Jiménez; Gloria de la Red; Ricard Cervera; Josep Font; Miguel Ingelmo
Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center.
Medicine 2001;80(4):252-62.
2001: Mario García-Carrasco; Manuel Ramos-Casals; Ricard Cervera; Olga Trejo; Jordi Yagüe; Antoni Sisó Almirall; Sònia Jiménez; Gloria de la Red; Josep Font; Miguel Ingelmo
Cryoglobulinemia in systemic lupus erythematosus: prevalence and clinical characteristics in a series of 122 patients.
Seminars in arthritis and rheumatism 2001;30(5):366-73.
2001: Ricard Cervera; Munther A Khamashta; Josep Font; G R V Hughes
European Working Party on Systemic Lupus Erythematosus: a 10 year report.
Lupus 2001;10(12):892-4.
2001: Ricard Cervera
The epidemiology and significance of autoimmune diseases in health care.
Scandinavian journal of clinical and laboratory investigation. Supplementum 2001;235():27-30.
2001: Manuel Ramos-Casals; Mario García-Carrasco; Ricard Cervera; José Rosas; Olga Trejo; Gloria de la Red; José M Sánchez-Tapias; Josep Font; Miguel Ingelmo
Hepatitis C virus infection mimicking primary Sjögren syndrome. A clinical and immunologic description of 35 cases.
Medicine 2001;80(1):1-8.
2001: Josep Font; Manuel Ramos-Casals; Ricard Cervera; Mario García-Carrasco; A Torras; Antoni Sisó Almirall; A Darnell; Miguel Ingelmo
Cardiovascular risk factors and the long-term outcome of lupus nephritis.
QJM : monthly journal of the Association of Physicians 2001;94(1):19-26.
2000: Manuel Ramos-Casals; Josep Font; Mario García-Carrasco; Ricard Cervera; S Jiménez; Olga Trejo; Gloria de la Red; José M Sánchez-Tapias; Miguel Ingelmo
Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus.
Arthritis and rheumatism 2000;43(12):2801-6.
2000: Josep Font; S Jiménez; Ricard Cervera; Mario García-Carrasco; Manuel Ramos-Casals; J Campdelacreu; Miguel Ingelmo
Splenectomy for refractory Evans' syndrome associated with antiphospholipid antibodies: report of two cases.
Annals of the rheumatic diseases 2000;59(11):920-3.
2000: Dolors Tàssies; Gerard Espinosa; FJ Muñoz-Rodríguez; Carolina Freire; Ricard Cervera; Joan Monteagudo; Santiago Maragall; Gines Escolar; Miguel Ingelmo; Antonio Ordinas; Josep Font; Joan Carles Reverter
The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome.
Arthritis and rheumatism 2000;43(10):2349-58.
2000: Gerard Espinosa; FJ Muñoz-Rodríguez; Ricard Cervera; Josep Font
[The etiopathogenic role of hepatitis virus C in the antiphospholipid syndrome].
Medicina clínica 2000;115(9):357-8.
2000: Ricard Cervera
Recent advances in antiphospholipid antibody-related valvulopathies.
Journal of autoimmunity 2000;15(2):123-5.
2000: Ronald A Asherson; Ricard Cervera
Catastrophic antiphospholipid syndrome.
Current opinion in hematology 2000;7(5):325-9.
2000: Manuel Ramos-Casals; Ricard Cervera; Mario García-Carrasco; J Vidal; Olga Trejo; Sònia Jiménez; J Costa; Josep Font; Miguel Ingelmo
Cytopenia and past human parvovirus B19 infection in patients with primary Sjögren's syndrome.
Seminars in arthritis and rheumatism 2000;29(6):373-8.
2000: FJ Muñoz-Rodríguez; Joan Carles Reverter; Josep Font; Dolors Tàssies; Ricard Cervera; Gerard Espinosa; Francisco Carmona; J Balasch; Antonio Ordinas; Miguel Ingelmo
Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
Haematologica 2000;85(6):632-7.
2000: M García-Carrasco; Manuel Ramos-Casals; Ricard Cervera; J Font
[Primary Sjögren's syndrome and lymphatic proliferation].
Medicina clínica 2000;114(19):740-6.
2000: Ronald A Asherson; Ricard Cervera
The catastrophic antiphospholipid syndrome: a review of pathogenesis, clinical features and treatment.
The Israel Medical Association journal : IMAJ 2000;2(4):268-73.
2000: Mario García-Carrasco; Pilar Pizcueta; Ricard Cervera; Manuel Ramos-Casals; Antoni Sisó Almirall; Gloria de la Red; Miguel Ingelmo; Josep Font; Pablo Engel
Circulating concentrations of soluble L-selectin (CD62L) in patients with primary Sjögren's syndrome.
Annals of the rheumatic diseases 2000;59(4):297-9.
2000: Manuel Ramos-Casals; Mario García-Carrasco; Ricard Cervera; J Gaya; I Halperin; I Ubieto; A Aymamí; RM Morlà; Josep Font; Miguel Ingelmo
Thyroid disease in primary Sjögren syndrome. Study in a series of 160 patients.
Medicine 2000;79(2):103-8.
2000: Manuel Ramos-Casals; Olga Trejo; Mario García-Carrasco; Ricard Cervera; Josep Font
Mixed cryoglobulinemia: new concepts.
Lupus 2000;9(2):83-91.
2000: Ricard Cervera; Josep Font; Manuel Ramos-Casals; Mario García-Carrasco; José Rosas; RM Morlà; F J Muñoz; A Artigues; Lucio Pallarés; Miguel Ingelmo
Primary Sjögren's syndrome in men: clinical and immunological characteristics.
Lupus 2000;9(1):61-4.
2000: J Rojas-Rodriguez; Mario Garcia-Carrasco; Manuel Ramos-Casals; G Enriquez-Coronel; C Colchero; Ricard Cervera; Josep Font
Catastrophic antiphospholipid syndrome: clinical description and triggering factors in 8 patients.
The Journal of rheumatology 2000;27(1):238-40.
2000: Josep Font; Pilar Pizcueta; Manuel Ramos-Casals; Ricard Cervera; Mario García-Carrasco; M Navarro; Miguel Ingelmo; Pablo Engel
Increased serum levels of soluble L-selectin (CD62L) in patients with active systemic lupus erythematosus (SLE).
Clinical and experimental immunology 2000;119(1):169-74.
1999: FJ Muñoz-Rodriguez; Josep Font; Ricard Cervera; Joan Carles Reverter; Dolors Tàssies; Gerard Espinosa; Alfonso López-Soto; Francisco Carmona; J Balasch; Antonio Ordinas; Miguel Ingelmo
Clinical study and follow-up of 100 patients with the antiphospholipid syndrome.
Seminars in arthritis and rheumatism 1999;29(3):182-90.
1999: Y Blanco; Manuel Ramos-Casals; Mario García-Carrasco; Ricard Cervera; Josep Font; Miguel Ingelmo
[Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: a report of 3 new cases and a review of the literature].
Revista clínica española 1999;199(9):586-8.
1999: Carlos Miret; Josep Font; Rafael Molina; Mario Garcia-Carrasco; Xavier Filella; M Ramos; Ricard Cervera; Antonio M Ballesta; Miguel Ingelmo
Bcl-2 oncogene (B cell lymphoma/leukemia-2) levels correlate with systemic lupus erythematosus disease activity.
Anticancer research 1999;19(4B):3073-6.
1999: FJ Muñoz-Rodríguez; Dolors Tàssies; Josep Font; Joan Carles Reverter; Ricard Cervera; José M Sánchez-Tapias; Roberto Mazzara; Antonio Ordinas; Miguel Ingelmo
Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome.
Journal of hepatology 1999;30(5):770-3.
1999: Ricard Cervera; Munther A Khamashta; Josep Font; gian domenico sebastiani; A Gil; P Lavilla; A O Aydintug; Anna Jedryka-Góral; Enrique de Ramón; Antonio Fernández-Nebro; Mauro Galeazzi; H J Haga; Alessandro Mathieu; Frédéric A Houssiau; G Ruiz-Irastorza; Miguel Ingelmo; G R V Hughes
Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus.
Medicine 1999;78(3):167-75.
1999: A Montehermoso; Ricard Cervera; Josep Font; Manuel Ramos-Casals; Mario García-Carrasco; F Formiga; JL Callejas; M Jorfán; M C Griñó; Miguel Ingelmo
Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus.
Seminars in arthritis and rheumatism 1999;28(5):326-32.
1999: Manuel Ramos-Casals; Mario García-Carrasco; Ricard Cervera; Josep Font
Sjögren's syndrome and hepatitis C virus.
Clinical rheumatology 1999;18(2):93-100.
1999: RM Morlà; Manuel Ramos-Casals; Mario García-Carrasco; Ricard Cervera; Josep Font; M Bruguera; Jorge Rojas-Rodríguez; Miguel Ingelmo
Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies: report of two cases and review of the literature.
Lupus 1999;8(2):160-3.
1999: Mario García-Carrasco; Ricard Cervera; José Rosas; Manuel Ramos-Casals; RM Morlà; Antoni Sisó Almirall; Sònia Jiménez; Lucio Pallarés; Josep Font; Miguel Ingelmo
Primary Sjögren's syndrome in the elderly: clinical and immunological characteristics.
Lupus 1999;8(1):20-3.
1998: Josep Font; Manuel Ramos-Casals; Ricard Cervera; X Bosch; E Mirapeix; Mario García-Carrasco; RM Morlà; Miguel Ingelmo
Antineutrophil cytoplasmic antibodies in primary Sjögren's syndrome: prevalence and clinical significance.
British journal of rheumatology 1998;37(12):1287-91.
1998: Manuel Ramos-Casals; Ricard Cervera; Jordi Yagüe; Mario García-Carrasco; Olga Trejo; Sònia Jiménez; RM Morlà; Josep Font; Miguel Ingelmo
Cryoglobulinemia in primary Sjögren's syndrome: prevalence and clinical characteristics in a series of 115 patients.
Seminars in arthritis and rheumatism 1998;28(3):200-5.
1998: Mauro Galeazzi; Gabriella Morozzi; gian domenico sebastiani; Francesca Bellisai; Roberto Marcolongo; Ricard Cervera; E De Ramòn Garrido; Antonio Fernandez-Nebro; Frédéric A Houssiau; Anna Jedryka-Goral; Alessandro Mathieu; Chryssa Papasteriades; Jean-Charles Piette; Raffaella Scorza; Josef Smolen
Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European Concerted Action on the Immunogenetics of SLE.
Clinical and experimental rheumatology 1998;16(5):541-6.
1998: Josep Font; Ricard Cervera; G Espinosa; Lucio Pallarés; Manuel Ramos-Casals; S Jiménez; Mario García-Carrasco; L Seisdedos; Miguel Ingelmo
Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults.
Annals of the rheumatic diseases 1998;57(8):456-9.
1998: Joan Carles Reverter; Dolors Tàssies; Josep Font; Munther A Khamashta; K Ichikawa; Ricard Cervera; Gines Escolar; G R V Hughes; Miguel Ingelmo; Antonio Ordinas
Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes.
Arthritis and rheumatism 1998;41(8):1420-7.
1998: R A Asherson; Ricard Cervera; J C Piette; Josep Font; J T Lie; A Burcoglu; K Lim; FJ Muñoz-Rodríguez; Roger levy; F Boué; J Rossert; Miguel Ingelmo
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients.
Medicine 1998;77(3):195-207.
1998: JL Callejas; F J Muñoz-Rodríguez; F Formiga; Ricard Cervera
[Cerebral venous thrombosis in Behçet's disease: manifestation despite anticoagulant treatment].
Revista clínica española 1998;198(4):263-4.
1998: Carlos Miret; Josep Font; Rafael Molina; Xavier Filella; J Vivancos; FJ Muñoz-Rodriguez; Ricard Cervera; Antonio M Ballesta; Miguel Ingelmo
Lack of correlation between tumor markers (CA 125 and SCC) and systemic lupus erythematosus activity.
Anticancer research 1998;18(2B):1341-4.
1998: J Ara; J Vivancos; J Soler-Carrillo; J C Paré; Ricard Cervera; Josep Font
Hypertrophic cardiomyopathy and systemic lupus erythematosus.
Clinical rheumatology 1998;17(6):531-3.
1998: Manuel Ramos-Casals; Ricard Cervera; Josep Font; Mario García-Carrasco; G Espinosa; S Reino; Lucio Pallarés; Miguel Ingelmo
Young onset of primary Sjögren's syndrome: clinical and immunological characteristics.
Lupus 1998;7(3):202-6.
1998: Josep Font; Dolors Tàssies; Mario García-Carrasco; Manuel Ramos-Casals; Ricard Cervera; Joan Carles Reverter; José M Sánchez-Tapias; Roberto Mazzara; Miguel Ingelmo
Hepatitis G virus infection in primary Sjögren's syndrome: analysis in a series of 100 patients.
Annals of the rheumatic diseases 1998;57(1):42-4.
1998: M Jorfén; JL Callejas; F Formiga; Ricard Cervera; Josep Font; Miguel Ingelmo
Fulminant thrombotic thrombocytopenic purpura in systemic lupus erythematosus.
Scandinavian journal of rheumatology 1998;27(1):76-7.
1997: S Reino; FJ Muñoz-Rodriguez; Ricard Cervera; Gerard Espinosa; Josep Font; Miguel Ingelmo
Optic neuropathy in the "primary" antiphospholipid syndrome: report of a case and review of the literature.
Clinical rheumatology 1997;16(6):629-31.
1997: Carlos Miret; Ricard Cervera; Joan Carles Reverter; Mario García-Carrasco; M Ramos; Meritxell Mollà; Josep Font; Miguel Ingelmo
Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome?
Clinical and experimental rheumatology 1997;15(5):541-4.
1997: Ricard Cervera; Mario García-Carrasco; Josep Font; M Ramos; Joan Carles Reverter; FJ Muñoz; Carlos Miret; Gerard Espinosa; Miguel Ingelmo
Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 80 patients.
Clinical and experimental rheumatology 1997;15(4):361-5.
1997: M Ramos; Ricard Cervera; Mario García-Carrasco; Carlos Miret; FJ Muñoz; Gerard Espinosa; Josep Font; Miguel Ingelmo
[Primary Sjögren's syndrome: clinical and immunologic study of 80 patients].
Medicina clínica 1997;108(17):652-7.
1997: Ricard Cervera; Ronald A Asherson; Josep Font; Mohammed Tikly; Lucio Pallarés; A Chamorro; Miguel Ingelmo
Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature.
Medicine 1997;76(3):203-12.
1997: Josep Font; Alfonso López-Soto; Ricard Cervera; F J Casals; Joan Carles Reverter; FJ Muñoz; Carlos Miret; Albert Bové; Antonio Ordinas; Miguel Ingelmo
Antibodies to thromboplastin in systemic lupus erythematosus: isotype distribution and clinical significance in a series of 92 patients.
Thrombosis research 1997;86(1):37-48.
1997: Alfonso López-Soto; Ricard Cervera; Josep Font; Albert Bové; Joan Carles Reverter; FJ Muñoz; Carlos Miret; Gerard Espinosa; Antonio Ordinas; Miguel Ingelmo
Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.
Clinical and experimental rheumatology 1997;15(2):143-9.
1997: Mario García-Carrasco; M Ramos; Ricard Cervera; Josep Font; J Vidal; FJ Muñoz; Carlos Miret; Gerard Espinosa; Miguel Ingelmo
Hepatitis C virus infection in 'primary' Sjögren's syndrome: prevalence and clinical significance in a series of 90 patients.
Annals of the rheumatic diseases 1997;56(3):173-5.
1997: M Navarro; Ricard Cervera; Josep Font; Joan Carles Reverter; Joan Monteagudo; Gines Escolar; Alfonso López-Soto; Antonio Ordinas; Miguel Ingelmo
Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance.
Lupus 1997;6(6):521-6.
1997: FJ Muñoz-Rodríguez; Josep Font; Joan Ramon Badia; Carlos Miret; Joan A Barberà; Ricard Cervera; Miguel Ingelmo
Shrinking lungs syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist therapy.
Lupus 1997;6(4):412-4.
1997: M Teixidó; Josep Font; Joan Carles Reverter; Ricard Cervera; Dolors Tàssies; Miguel Ingelmo; Gines Escolar; Antonio Ordinas
Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome.
British journal of rheumatology 1997;36(1):113-6.
1997: L Seisdedos; FJ Muñoz-Rodríguez; Ricard Cervera; Josep Font; Miguel Ingelmo
Primary antiphospholipid syndrome evolving into systemic lupus erythematosus.
Lupus 1997;6(3):285-6.
1996: Maria C Cid; Joan Monteagudo; J Oristrell; Jaime Vilaseca; L Pallarés; Ricard Cervera; Carme Font; Josep Font; Miguel Ingelmo; Alvaro Urbano-Márquez
Von Willebrand factor in the outcome of temporal arteritis.
Annals of the rheumatic diseases 1996;55(12):927-30.
1996: M Navarro; Ricard Cervera; M Teixidó; Joan Carles Reverter; Josep Font; Alfonso López-Soto; Joan Monteagudo; Gines Escolar; Miguel Ingelmo
Antibodies to endothelial cells and to beta 2-glycoprotein I in the antiphospholipid syndrome: prevalence and isotype distribution.
British journal of rheumatology 1996;35(6):523-8.
1996: Meritxell Mollà; Carlos Miret; B Sarasà; Ricard Cervera
[Bacteremia caused by Achromobacter xylosidans].
Medicina clínica 1996;106(1):38.
1995: Josep Font; Josep Vidal; Ricard Cervera; Alfonso López-Soto; Carlos Miret; M Teresa Jiménez de Anta; Miguel Ingelmo
Lack of relationship between human immunodeficiency virus infection and systemic lupus erythematosus.
Lupus 1995;4(1):47-9.
1995: Ricard Cervera; R A Asherson; J T Lie
Clinicopathologic correlations of the antiphospholipid syndrome.
Seminars in arthritis and rheumatism 1995;24(4):262-72.
1994: R A Asherson; Ricard Cervera
'Primary', 'secondary' and other variants of the antiphospholipid syndrome.
Lupus 1994;3(4):293-8.
1994: J Vivancos; Alfonso López-Soto; Josep Font; J Balasch; Ricard Cervera; Joan Carles Reverter; Francisco Carmona; Miguel Ingelmo
[Primary antiphospholipid syndrome: clinical and biological study of 36 cases].
Medicina clínica 1994;102(15):561-5.
1994: Ricard Cervera; M Navarro; Alfonso López-Soto; Maria C Cid; Josep Font; J Esparza; Joan Carles Reverter; Joan Monteagudo; Miguel Ingelmo; Alvaro Urbano-Márquez
Antibodies to endothelial cells in Behçet's disease: cell-binding heterogeneity and association with clinical activity.
Annals of the rheumatic diseases 1994;53(4):265-7.
1993: Josep Font; Ricard Cervera
1982 revised criteria for classification of systemic lupus erythematosus--ten years later.
Lupus 1993;2(5):339-41; discussion 343.
1993: A O Aydìntug; Güner Tokgöz; David D'Cruz; Aysel Gürler; Ricard Cervera; Nursen Düzgün; L S Atmaca; Munther A Khamashta; G R V Hughes
Antibodies to endothelial cells in patients with Behçet's disease.
Clinical immunology and immunopathology 1993;67(2):157-62.
1993: Josep Font; L Pallarés; Ricard Cervera; J Vivancos; Alfonso López-Soto; C Herrero; Alejandro Darnell; A Torras; Eduard Mirapeix; J A del Olmo
[Systemic lupus erythematosus: a clinical and immunological study of 300 patients].
Medicina clínica 1993;100(16):601-5.
1993: Ricard Cervera; Munther A Khamashta; Josep Font; gian domenico sebastiani; A Gil; P Lavilla; I Doménech; A O Aydintug; A Jedryka-Góral; E de Ramón
Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus.
Medicine 1993;72(2):113-24.
1993: David D'Cruz; Ricard Cervera; A Olcay Aydintug; T Ahmed; Josep Font; G R V Hughes
Systemic lupus erythematosus evolving into systemic vasculitis: a report of five cases.
British journal of rheumatology 1993;32(2):154-7.
1992: A O Aydintug; I Domenech; Ricard Cervera; Munther A Khamashta; A Jedryka-Goral; J L Vianna; G R V Hughes
Systemic lupus erythematosus in males: analysis of clinical and laboratory features.
Lupus 1992;1(5):295-8.
1992: Josep Font; Ricard Cervera; M Navarro; L Pallarés; Alfonso López-Soto; J Vivancos; Miguel Ingelmo
Systemic lupus erythematosus in men: clinical and immunological characteristics.
Annals of the rheumatic diseases 1992;51(9):1050-2.
1992: Xavier Bosch; Eduard Mirapeix; Josep Font; Ricard Cervera; Miguel Ingelmo; Munther A Khamashta; L Revert; G R Hughes; Alvaro Urbano-Márquez
Anti-myeloperoxidase autoantibodies in patients with necrotizing glomerular and alveolar capillaritis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1992;20(3):231-9.
1992: R A Asherson; Ricard Cervera; Josep Font
Multiorgan thrombotic disorders in systemic lupus erythematosus: a common link?
Lupus 1992;1(4):199-203.
1992: I Domenech; O Aydintug; Ricard Cervera; Munther A Khamashta; A Jedryka-Goral; J L Vianna; G R V Hughes
Systemic lupus erythematosus in 50 year olds.
Postgraduate medical journal 1992;68(800):440-4.
1992: I Doménech; Ricard Cervera; Munther A Khamashta
[Lipoproteins and atherosclerosis in systemic lupus erythematosus].
Medicina clínica 1992;98(19):749-52.
1992: A O Aydintug; David D'Cruz; Ricard Cervera; Munther A Khamashta; G R V Hughes
Low dose methotrexate treatment in adult Still's disease.
The Journal of rheumatology 1992;19(3):431-5.
1992: J Montalbán; Ricard Cervera; Josep Font; J Ordi; J Vianna; Hans-Jacob Haga; Mar Tintoré; Munther A Khamashta; G R V Hughes
Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus.
Neurology 1992;42(3 Pt 1):681-2.
1992: J L Vianna; Hans-Jacob Haga; P Tripathi; Ricard Cervera; Munther A Khamashta; G R V Hughes
Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus.
Annals of the rheumatic diseases 1992;51(2):160-1.
1992: Ricard Cervera; Josep Font; Carles Paré; Manel Azqueta; F Pérez-Villa; Alfonso López-Soto; Miguel Ingelmo
Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients.
Annals of the rheumatic diseases 1992;51(2):156-9.
1992: R A Asherson; Ricard Cervera
The antiphospholipid syndrome: a syndrome in evolution.
Annals of the rheumatic diseases 1992;51(2):147-50.
1991: Ricard Cervera; Munther A Khamashta; Josep Font; P A Reyes; J L Vianna; Alfonso López-Soto; M C Amigo; R A Asherson; Manel Azqueta; Carles Paré
High prevalence of significant heart valve lesions in patients with the 'primary' antiphospholipid syndrome.
Lupus 1991;1(1):43-7.
1991: A O Aydintug; Ricard Cervera; David D'Cruz; G Ramírez; R A Asherson; Munther A Khamashta; G R V Hughes
Polymyositis complicating D-penicillamine treatment.
Postgraduate medical journal 1991;67(793):1018-20.
1991: Josep Font; L Pallarés; Ricard Cervera; Alfonso López-Soto; M Navarro; Xavier Bosch; Miguel Ingelmo
Systemic lupus erythematosus in the elderly: clinical and immunological characteristics.
Annals of the rheumatic diseases 1991;50(10):702-5.
1991: Josep Font; Ricard Cervera; Carles Paré; Alfonso López-Soto; L Pallarés; Manel Azqueta; Munther A Khamashta
Non-infective verrucous endocarditis in a patient with 'primary' antiphospholipid syndrome.
British journal of rheumatology 1991;30(4):305-7.
1991: Ricard Cervera; G Ramírez; Joaquim Fernández-Solà; David D'Cruz; Jordi Casademont; Josep M Grau; R A Asherson; Munther A Khamashta; Alvaro Urbano-Márquez; G R V Hughes
Antibodies to endothelial cells in dermatomyositis: association with interstitial lung disease.
BMJ (Clinical research ed.) 1991;302(6781):880-1.
1991: G R Hughes; Ricard Cervera
[Systemic lupus erythematosus: new perspectives].
Medicina clínica 1991;96(6):229-35.
1991: Ricard Cervera; Munther A Khamashta; Josep Font; G Ramírez; David D'Cruz; J Montalbán; Alfonso López-Soto; R A Asherson; Miguel Ingelmo; G R V Hughes
Antiendothelial cell antibodies in patients with the antiphospholipid syndrome.
Autoimmunity 1991;11(1):1-6.
1991: Josep Font; Alfonso López-Soto; Ricard Cervera; Juan Balasch; L Pallarés; M Navarro; Xavier Bosch; Miguel Ingelmo
The 'primary' antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients.
Autoimmunity 1991;9(1):69-75.
1990: Ricard Cervera; J Montalbán; Munther A Khamashta
[Antiendothelial cell antibodies].
Medicina clínica 1990;95(18):712-5.
1990: G Ramírez; R A Asherson; Munther A Khamashta; Ricard Cervera; David D'Cruz; G R V Hughes
Adult-onset polymyositis-dermatomyositis: description of 25 patients with emphasis on treatment.
Seminars in arthritis and rheumatism 1990;20(2):114-20.
1990: Josep Font; J Valls; Ricard Cervera; A Pou; Miguel Ingelmo; Francesc Graus
Pure sensory neuropathy in patients with primary Sjögren's syndrome: clinical, immunological, and electromyographic findings.
Annals of the rheumatic diseases 1990;49(10):775-8.
1990: Maria C Cid; Ricard Cervera; Josep Font; A Lopez-Soto; L Pallarés; M Navarro; Miguel Ingelmo
Late thrombotic events in patients with temporal arteritis and anticardiolipin antibodies.
Clinical and experimental rheumatology 1990;8(4):359-63.
1990: Munther A Khamashta; Ricard Cervera; R A Asherson; Josep Font; A Gil; D J Coltart; J J Vázquez; Carles Paré; Miguel Ingelmo; J Oliver
Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus.
Lancet 1990;335(8705):1541-4.
1990: R A Asherson; Munther A Khamashta; Ricard Cervera; D McGibbon; A D Lulu; G R Hughes
[Diabetic cheirarthropathy simulating sclerodermia].
Medicina clínica 1990;94(18):702-3.
1990: Ricard Cervera; Josep Font; Alfonso López-Soto; F Casals; L Pallarés; Albert Bové; Miguel Ingelmo; Alvaro Urbano-Márquez
Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients.
Annals of the rheumatic diseases 1990;49(2):109-13.
1990: Juan Balasch; Josep Font; Alfonso López-Soto; Ricard Cervera; I Jové; F J Casals; Juan A Vanrell
Antiphospholipid antibodies in unselected patients with repeated abortion.
Human reproduction (Oxford, England) 1990;5(1):43-6.
1989: Josep Font; Ricard Cervera; A Lopez-Soto; L Pallares; Xavier Bosch; S Ampurdanes; F J Casals; Miguel Ingelmo
Anticardiolipin antibodies in patients with autoimmune diseases: isotype distribution and clinical associations.
Clinical rheumatology 1989;8(4):475-83.
1989: Alfonso López-Soto; F J Casals; Josep Font; Ricard Cervera; Miguel Ingelmo
Detection of antiphospholipid antibodies by ELISA-method with bovine thromboplastin as antigen.
Thrombosis research 1989;53(6):623-8.
1988: Josep Font; Ricard Cervera; L Pallarés; Alfonso López-Soto; Miguel Ingelmo
Systemic lupus erythematosus and monoclonal gammopathy.
British journal of rheumatology 1988;27(5):412-3.
1988: Josep Font; Ricard Cervera; F J Casals; Albert Bové; A Guerrero; Alfonso López-Soto; Miguel Ingelmo; Alvaro Urbano-Márquez
[Relation of antiphospholipid antibodies to thrombotic phenomena and clinical activity of systemic lupus erythematosus].
Medicina clínica 1988;90(12):490-3.
1987: Josep Font; Ricard Cervera; Albert Bové; F J Casals
[Antiphospholipid antibodies as markers of systemic lupus erythematosus].
Medicina clínica 1987;89(12):528.
1987: Josep Font; F J Casals; Ricard Cervera; Albert Bové
[Anticardiolipin antibodies and thrombosis in systemic lupus erythematosus].
Medicina clínica 1987;89(1):41.